Browsing NTNU Open by Author "Aasbrenn, Martin"
Now showing items 1-8 of 8
-
A conservative weight loss intervention relieves bowel symptoms in morbidly obese subjects with irritable bowel syndrome: a prospective cohort study
Aasbrenn, Martin; Lydersen, Stian; Farup, Per Grønaas (Journal article; Peer reviewed, 2018)Background. Irritable bowel syndrome (IBS) is common in subjects with morbid obesity; the effect of weight loss programs on bowel symptoms is largely unknown. Methods. This prospective cohort study explored bowel symptoms, ... -
Anti-Saccharomyces cerevisae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study
Kvehaugen, Anne Stine; Aasbrenn, Martin; Farup, Per Grønaas (Journal article; Peer reviewed, 2017)Baker’s/brewer’s yeast, Saccharomyces cerevisiae, has been used as an alternative to antibiotic growth promoters to improve growth performance in animals. In humans, Saccharomyces cerevisiae is among the most commonly ... -
Changes in C-reactive protein, neopterin and lactoferrin differ after conservative and surgical weight loss in individuals with morbid obesity
Aasbrenn, Martin; Farup, Per Grønaas; Videm, Vibeke (Journal article; Peer reviewed, 2019)C-reactive protein, neopterin and lactoferrin are biomarkers of atherosclerotic disease. We aimed to assess changes in these biomarkers after conservative and surgical weight loss interventions in individuals with morbid ... -
Intake of non-nutritive sweeteners is associated with an unhealthy lifestyle: a cross-sectional study in subjects with morbid obesity
Winther, Robert; Aasbrenn, Martin; Farup, Per Grønaas (Journal article; Peer reviewed, 2017)Background Subjects with morbid obesity commonly use Non-Nutritive Sweeteners (NNS), but the health-related effects of NNS have been questioned. The objectives of this study were to explore the associations between ... -
Irritable bowel syndrome in subjects with morbid obesity: Observational studies of patients at outpatient clinics
Aasbrenn, Martin (Doctoral theses at NTNU;2018:136, Doctoral thesis, 2018) -
Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study
Høgestøl, Ingvild Kristine; Aasbrenn, Martin; Chahal-Kummen, Monica; Brunborg, Cathrine; Eribe, Inger; Kristinsson, Jon Adalsteinn; Farup, Per Grønaas; Mala, Tom (Journal article; Peer reviewed, 2019)BACKGROUND: Irritable bowel syndrome (IBS) is prevalent in patients with morbid obesity. After Roux-en-Y gastric bypass (RYGB) chronic abdominal pain is common, however the etiology is largely unknown. We aimed to study ... -
Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study
Aasbrenn, Martin; Høgestøl, Ingvild Kristine; Eribe, Inger; Kristinsson, Jon Adalsteinn; Lydersen, Stian; Mala, Tom; Farup, Per Grønaas (Journal article; Peer reviewed, 2017)Background Irritable bowel syndrome has been reported as more common in patients with morbid obesity than in the general population. The reason for this association is unknown. The aims of this study were to study the ... -
Separating “good” from “bad” faecal dysbiosis – evidence from two cross-sectional studies
Farup, Per Grønaas; Aasbrenn, Martin; Valeur, Jørgen (Journal article; Peer reviewed, 2018)Background Faecal dysbiosis associated with the use of metformin has been conceived as a favourable (“good”) dysbiosis and that with intake of non-nutritive sweeteners (NNS) as unfavourable (“bad”). The study aimed to ...